LA JOLLA, Calif., November 2, 2010 - It's no secret that obesity is hard on the heart. More than 30 percent of Americans are obese, and many of them are also at increased risk for cancer, diabetes and heart disease. However, there are numerous causes of obesity and other risk factors for each of these conditions, making it difficult to tease them apart. At Sanford-Burnham Medical Research Institute (Sanford-Burnham), a team led by Sean Oldham, Ph.D., and Rolf Bodmer, Ph.D., recently created a simple model to link high-fat diet, obesity and heart dysfunction. Using fruit flies, they discovered that a protein called TOR influences fat accumulation in the heart. Their study, published November 3 in the journal Cell Metabolism, also demonstrates that manipulating TOR protects the hearts of obese flies from damage caused by high-fat diets.
"We noticed previously that reducing TOR had a large number of beneficial effects on aging," explained Dr. Oldham, co-senior author of the study. "We next wanted to look at TOR activity in obesity-related heart disease, but we didn't have a good system. In this study, we establish the fruit fly as a model for obesity caused by a high-fat diet."
The fruit fly model is ideal for studying the heart because most of the basic molecular mechanisms controlling its development are surprisingly similar to those in vertebrates - even somewhat interchangeable. What's more, it's relatively easy to delete individual genes in the fly, allowing researchers to specifically map out each one's role in heart development and function.
In this study, flies fed a high-fat diet of coconut oil became obese and exhibited many of the same secondary symptoms as obese humans, including heart dysfunction. Then, to determine how TOR regulates the effects of fat on the heart, Dr. Oldham and colleagues generated flies that lowered this protein's activity. TOR normally keeps a damper on an enzyme that breaks down fats. By inhibiting TOR (or boosting the fat-digesting enzyme), the researchers reduced fat accumulation in the heart and improved the cardiac health of otherwise obese flies. The heart-protective results were the same whether TOR was blocked in the whole fly, just in fat tissue or just in heart cells.
According to Dr. Bodmer, co-senior author of the study and professor and director of the Development and Aging Program, "These results open the possibility that we can intervene with the effects of obesity by targeting TOR and other proteins it regulates - either directly in fat or in a specific organ like the heart."
This fruit fly model will now allow researchers to answer many other questions about diet, obesity and the heart. "One thing we'd like to know next is if fats themselves are toxic to the heart, or is it the byproducts of their metabolism that are harmful?" said Dr. Birse, post-doctoral researcher and first/lead author of the study. "One good thing about using fruit flies is that, in theory, we could feed them whatever we want to screen - different fatty acids, molecules, drugs, etc. - to observe their effects on the heart or other systems."
The study was funded by the American Heart Association (AHA), the Ellison Medical
Foundation, and the National Heart, Lung and Blood Institute (NHLBI) at the National Institutes of Health (NIH). Support for this project was also provided by the Sanford Children's Health Research Center at Sanford-Burnham. For more information about Sanford-Burnham research, visit http://beaker.
Original paper Birse RT, Choi J, Reardon K, Rodriguez J, Graham S, Diop S, Ocorr K, Bodmer R, Oldham S. High fat diet-induced obesity and heart dysfunction is regulated by the TOR pathway in Drosophila. Cell Metabolism. November 3, 2010.
About Sanford-Burnham Medical Research Institute
Sanford-Burnham Medical Research Institute is dedicated to discovering the fundamental molecular causes of disease and devising the innovative therapies of tomorrow. Sanford-Burnham, with operations in California and Florida, is one of the fastest-growing research institutes in the country. The Institute ranks among the top independent research institutions nationally for NIH grant funding and among the top organizations worldwide for its research impact. From 1999 - 2009, Sanford-Burnham ranked #1 worldwide among all types of organizations in the fields of biology and biochemistry for the impact of its research publications, defined by citations per publication, according to the Institute for Scientific Information. According to government statistics, Sanford-Burnham ranks #2 nationally among all organizations in capital efficiency of generating patents, defined by the number of patents issued per grant dollars awarded.
Sanford-Burnham utilizes a unique, collaborative approach to medical research and has established major research programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. The Institute is especially known for its world-class capabilities in stem cell research and drug discovery technologies. Sanford-Burnham is a nonprofit public benefit corporation. For more information, please visit www.sanfordburnham.org.